Filing Details
- Accession Number:
- 0001209191-21-059842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-06 16:38:55
- Reporting Period:
- 2021-10-04
- Accepted Time:
- 2021-10-06 16:38:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | F-Star Therapeutics Inc. | FSTX | Pharmaceutical Preparations (2834) | 522386345 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831519 | Louis Kayitalire | C/O F-Star Therapeutics, Inc. Eddeva B920, Babraham Research Campus Cambridge X0 CB22 3AT | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-04 | 64 | $7.23 | 54,319 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- Includes 47,175 restricted stock units.
Billionaire Hedge Funds
